NexImmune

YTD

ALL

Why Robinhood?

You can watch NexImmune and buy or sell other stocks, ETFs, and their options commission-free!

About NEXI

NexImmune, Inc. is a clinical stage biotechnology company, which engages in the development of novel approach to immunotherapy designed to employ the body’s own T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.

CEO

Kristi Jones

CEOKristi Jones

Employees

Employees50

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

2011

Founded2011

Employees

Employees50

NEXI Key Statistics

Market cap

64.97M

Market cap64.97M

Price-Earnings ratio

-0.09

Price-Earnings ratio-0.09

Dividend yield

—

Dividend yield—

Average volume

191.69K

Average volume191.69K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.814

52 Week high$0.814

52 Week low

$0.15

52 Week low$0.15